CLASS III Device recall · Reported 30 Oct 2013 · FDA Enforcement Report

FSE Image Upgrade Kit recalled by Bio-Rad Laboratories

Bio-Rad Laboratories is recalling FSE Image Upgrade Kit, distributed in 10 states. The recall was initiated on 20 Aug 2013 and the FDA has classified it as Class III.

Check your package

Lot, batch or date codesLot 122822
Quantity recalled23 kits

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0032-2014
FDA event ID
66293
Recalling firm
Bio-Rad Laboratories, Redmond, WA
Classification
Class III
Status
Terminated
Recall initiated
20 Aug 2013
FDA classified
21 Oct 2013
Reported
30 Oct 2013
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction
Device type
Medical Software

Timeline

20 Aug 2013Recall initiated by company
21 Oct 2013Classified by FDA+62 days
30 Oct 2013Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The FSE Image Upgrade kit (part 92019C) is recalled due to issue related to the export of data from the EVOLIS analyzer to Laboratory Information Systems (LIS) when using the MONOLISA Anti-HBs EIA Quantitative Determination in EVOLIS APF version 6.0.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

FSE Image Upgrade Kit, Catalog # 92019C This kit is used to install and/or upgrade software used with the EVOLIS Microplate System.

Where it was distributed

US Distribution including the states of FL, IA, ME, MO, MS, NE, NY, TN, TX, and WA

FloridaIowaMaineMissouriMississippiNebraskaNew YorkTennesseeTexasWashington

Questions about this recall

Why was it recalled?

The FSE Image Upgrade kit (part 92019C) is recalled due to issue related to the export of data from the EVOLIS analyzer to Laboratory Information Systems (LIS) when using the MONOLISA Anti-HBs EIA Quantitative Determination in EVOLIS APF version 6.0.

Which lots are affected?

Lot 122822

Where was it sold?

US Distribution including the states of FL, IA, ME, MO, MS, NE, NY, TN, TX, and WA

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class III mean?

Class III recalls are for products unlikely to cause any adverse health consequence, usually labelling or quality issues.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Bio-Rad Laboratories

All 27

Other Medical Software recalls

All 932